Found 55 matching trials
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was designed to investigate the 1 year efficacy and safety of th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The primary objective of this trial was to establish non-inferiority of lun...
Show More Location
Multiple Locations
Learn More & Join Trial
Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease PHASE2 The primary objective of this study is to assess the efficacy of Glycopyrro...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD PHASE2 The overall objective of this study is to determine an optimal dose and dos...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE1 The primary objective of this study is to assess and compare the pharmacoki...
Show More Location
Teva Investigational Site 32170
Learn More & Join Trial
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The purpose of this study is to further figure out differences of glycopyrr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
AMPLIFY - D6571C00001 Duaklir USA Phase III Study PHASE3 This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Show More Learn More & Join Trial
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1 PHASE4 A randomized, placebo-controlled, double-blind, parallel group, multi cente...
Show More Location
205.477.001039 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients NA The aim of this study was to compare the tiotropium Respimat Soft Mist Inha...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD) PHASE3 Study to evaluate the pharmacokinetics of tiotropium following 14 days of a...
Show More Location
Multiple Locations
Learn More & Join Trial